drugset / Trial / NCT01465152
Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to compare the efficacy of metformin and repaglinide used alone or combined administered as initial treatment in subjects with type 2 diabetes in which diet and exercise have failed.
Timeline
- Start
- 2002-03-06
- Primary completion
- 2004-10-21
- Completion
- 2004-10-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | — | Oral |
| Comparator | Repaglinide | Small molecule | — | Oral |